SPIRAMYCIN: 925 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
925
Total FAERS Reports
179 (19.4%)
Deaths Reported
519
Hospitalizations
925
As Primary/Secondary Suspect
131
Life-Threatening
2
Disabilities
First Report: 20010101 · Latest Report: 20250328
What Are the Most Common SPIRAMYCIN Side Effects?
#1 Most Reported
Off label use
77 reports (8.3%)
#2 Most Reported
Cholestasis
75 reports (8.1%)
#3 Most Reported
Rash maculo-papular
70 reports (7.6%)
All SPIRAMYCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 77 | 8.3% | 20 | 44 |
| Cholestasis | 75 | 8.1% | 0 | 57 |
| Rash maculo-papular | 70 | 7.6% | 12 | 40 |
| Hepatocellular injury | 68 | 7.4% | 3 | 46 |
| Toxic epidermal necrolysis | 65 | 7.0% | 46 | 63 |
| Eosinophilia | 44 | 4.8% | 12 | 28 |
| Acute kidney injury | 42 | 4.5% | 3 | 36 |
| Pyrexia | 41 | 4.4% | 16 | 39 |
| Rhabdomyolysis | 37 | 4.0% | 24 | 16 |
| Thrombocytopenia | 37 | 4.0% | 5 | 31 |
| Acute generalised exanthematous pustulosis | 34 | 3.7% | 0 | 27 |
| Drug ineffective | 32 | 3.5% | 18 | 23 |
| Drug reaction with eosinophilia and systemic symptoms | 32 | 3.5% | 0 | 25 |
| Maternal exposure during pregnancy | 32 | 3.5% | 4 | 16 |
| Hepatic cytolysis | 27 | 2.9% | 0 | 22 |
| Hypertransaminasaemia | 26 | 2.8% | 12 | 4 |
| Condition aggravated | 25 | 2.7% | 10 | 21 |
| Septic shock | 24 | 2.6% | 21 | 9 |
| Foetal exposure during pregnancy | 23 | 2.5% | 11 | 1 |
| Dyspnoea | 21 | 2.3% | 5 | 16 |
Who Reports SPIRAMYCIN Side Effects? Age & Gender Data
Gender: 40.5% female, 59.5% male. Average age: 59.7 years. Most reports from: FR. View detailed demographics →
Is SPIRAMYCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 0 |
| 2012 | 1 | 1 | 1 |
| 2013 | 8 | 6 | 6 |
| 2014 | 27 | 1 | 14 |
| 2015 | 71 | 11 | 54 |
| 2016 | 37 | 5 | 25 |
| 2017 | 50 | 7 | 37 |
| 2018 | 71 | 2 | 35 |
| 2019 | 94 | 25 | 56 |
| 2020 | 174 | 63 | 108 |
| 2021 | 60 | 9 | 45 |
| 2022 | 57 | 4 | 18 |
| 2023 | 50 | 14 | 20 |
| 2024 | 37 | 0 | 20 |
| 2025 | 20 | 0 | 8 |
What Is SPIRAMYCIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 123 |
| Pneumonia | 108 |
| Lung disorder | 106 |
| Infection | 73 |
| Toxoplasmosis | 34 |
| Bronchitis | 33 |
| Sepsis | 31 |
| Legionella infection | 27 |
| Covid-19 | 26 |
| Antibiotic therapy | 25 |
SPIRAMYCIN vs Alternatives: Which Is Safer?
SPIRAMYCIN vs SPIRIVA
SPIRAMYCIN vs SPIRONOLACTONE
SPIRAMYCIN vs SPRYCEL
SPIRAMYCIN vs STALEVO
SPIRAMYCIN vs STANNOUS FLUORIDE
SPIRAMYCIN vs STANOZOLOL
SPIRAMYCIN vs STAVUDINE
SPIRAMYCIN vs STELARA
SPIRAMYCIN vs STIRIPENTOL
SPIRAMYCIN vs STIVARGA
Official FDA Label for SPIRAMYCIN
Official prescribing information from the FDA-approved drug label.